«Oncology Cancer

Below is an extended Oncology Cancer patents listing. Click here to return to the Oncology Cancer main in depth entry.

Patents :
US Patent No.	Title
6103261	Opioid formulations having extended controlled release
6599938	Compounds having MIF antagonist activity
6667034	METHODS FOR REGULATING THE SPECIFIC LINEAGES OF CELLS PRODUCED IN A HUMAN HEMATOPOIETIC CELL CULTURE, METHODS FOR ASSAYING THE EFFECT OF SUBSTANCES ON LINEAGE-SPECIFIC CELL PRODUCTION, AND CELL COMPOSITIONS PRODUCED BY THESE CULTURES
6670147	Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use
6686344	Organic-arsonic compounds
6693100	Pharmaceutical compositions for treating psoriasis
6703375	Molecular chemotherapy enhancement of radiotherapy
6733783	Controlled release hydrocodone formulations
6746848	Protein quantitation with cell imaging densitometry
6749853	Combined methods and compositions for coagulation and tumor treatment
6806294	Opioid analgesic
6599909	Molecular chemotherapy enhancement of radiotherapy
6572885	Orally administrable opioid formulations having extended duration of effect
6552005	Molecular chemotherapy enhancement of radiotherapy
6143322	Method of treating humans with opioid formulations having extended controlled release
6184043	Method for detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
6230501	Ergonomic systems and methods providing intelligent adaptive surfaces and temperature control
6265229	Method and device for detection of specific target cells in specialized or mixed cell populations and solutions containing mixed cell populations
6294195	Orally administrable opioid formulations having extended duration of effect
6399096	Pharmaceutical formulation
6451312	VEGF-gelonin for targeting the vasculature of solid tumors
6465246	Oncogene- or virus-controlled expression systems
6482815	Organic-arsenic compounds
6482816	Organic arsenic compounds
6835566	Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses
6865825	Ergonomic systems and methods providing intelligent adaptive surfaces and temperature control
7204041	Ergonomic systems and methods providing intelligent adaptive surfaces
7238667	Albumin fusion proteins
7241742	CYP1B1 nucleic acids and methods of use
7259188	Methods and pharmaceutical compositions for treatment of anti-estrogen resistant breast cancer using RXR modulators
7270831	Orally administrable opioid formulations having extended duration of effect
7371780	Use of calphostin C to treat drug-resistant tumor cells
7378445	Treatment of prostate cancer
7402298	EphA2 monoclonal antibodies and methods of making and using same
7410656	Anti-cancer compounds
7416746	Method for cancer therapy using herbal extracts
7198787	Method of killing target cells in harvested cell populations with one or more immuno-toxins
7196060	Method to enhance hematopoiesis
7192698	EphA2 as a diagnostic target for metastatic cancer
6893881	Method for detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
6927203	Treatment of metastatic disease
7026281	Antagonistic analogs of GH-RH inhibiting IGF-I and -II
7041653	Gene transcription and ionizing radiation: methods and compositions
7078376	Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects
7101976	EphA2 monoclonal antibodies and methods of making and using same
7107706	Ergonomic systems and methods providing intelligent adaptive surfaces and temperature control
7125541	Combined methods for tumor vasculature targeting and tumor treatment with radiotherapy
7141547	Albumin fusion proteins comprising GLP-1 polypeptides
7173021	Synthesis of temozolomide esters as potent anticancer pro-drugs for topical and transdermal applications in treatments of cancers
7428554	System and method for determining matching patterns within gene expression data

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.